Compared with high-intensity statin therapy, moderate intensity statin therapy plus ezetimibe was equally effective in preventing CV events among patients undergoing PCI. Moderate-intensity statin ...

CHICAGO, IL – It's been a full 365 days since the American College of Cardiology (ACC) and American Heart Association (AHA) presented their "paradigm-shifting" clinical guidelines for the management ...

The combination of ezetimibe and a moderate-intensity statin after coronary stenting may be safer and more clinically effective than monotherapy with a high-intensity statin, suggests a "real-world" ...

Statins are among the most commonly prescribed medications for reducing high cholesterol and lowering the risk of heart attack and stroke. People searching for popular statin medications are often ...

More than one in four patients in the United States with atherosclerotic cardiovascular disease (ASCVD) are not on a guideline-recommended statin or other lipid-lowering therapy, with suboptimal ...

Patients with established clinical ASCVD Patients with severe primary hypercholesterolemia (a baseline LDL-C level ≥190 mg/dL) Patients 40-75 years of age with diabetes and a baseline LDL-C level of ...

In February 2024, the U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (ARV Guidelines Panel), in collaboration with the ...

Cholesterol disorders affect millions of people globally and are among the leading risk factors for cardiovascular diseases, including heart attack and stroke. Statins are the first-line therapy for ...

Ms. C*, a 53-year-old African American woman living with HIV for almost a decade, inquired about the recently released recommendations for cardiovascular disease prevention among people with HIV (PWH) ...